Monoclonal antibodies blocking CGRP for prevention of migraine
Introduction and purpose Monoclonal antibodies blocking calcitonin gene-related peptide (CGRP) are a novel treatment strategy developed specifically for prevention of migraine. Four drugs belong to this group: eptinezumab, fremanezumab and galcanezumab, which bind to the peptide; and erenumab, w...
محفوظ في:
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Kazimierz Wielki University
2023-04-01
|
| سلاسل: | Journal of Education, Health and Sport |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://apcz.umk.pl/JEHS/article/view/43098 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|